跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 177 条关于
“Fortitude Biomedicines”
全部
177
临床试验
13
药物
82
机构
11
资讯
71
7个月前
Fortitude Biomedicines Launches with $13M Seed Funding to Advance Novel GLUE-DAC Platform for Cancer and Autoimmune Diseases
6个月前
HYDRACs: Protein-Like Polymers Open New Frontier in Targeted Protein Degradation for Undruggable Cancer Targets
去年
Avidity Biosciences Advances AOC 1020 for FSHD with Biomarker Cohort in FORTITUDE Trial
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
去年
Avidity Biosciences Initiates Biomarker Cohort in Phase 1/2 FORTITUDE Trial for FSHD Therapy
去年
Sail Biomedicines Advances Novel In Vivo eRNA CAR-T Therapy for Autoimmune Diseases
去年
Eli Lilly Invests in Ampersand Biomedicines' $65M Series B for Precision Drug Delivery Platform
去年
Endeavor BioMedicines Receives Dual Orphan Drug Designation for Taladegib in Idiopathic Pulmonary Fibrosis
5个月前
Flagship Pioneering Launches Serif Biomedicines with $50M to Pioneer Modified DNA Therapeutics
6个月前
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track Designation for ALK+ NSCLC Treatment
第 1 页,共 8 页
上一页
下一页